Back to Journals » Breast Cancer: Targets and Therapy » Volume 4

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Total article views   Abstract views HTML views PDF downloads Totals
11,286 Dovepress* 9,410 514+ 2,804 9,924
PubMed Central* 1 1,361 1,370 1,362
Totals 9,411 1,875 4,174 11,286
*Since 27 August 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 4 4

View citations on PubMed Central and Google Scholar